batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Astra and Fusion’s actinium bet is on 8 May 2024 Nanjing Leads the co-stimulatory charge 7 May 2024 Bristol moves to leapfrog Merck 7 May 2024 CytomX raises hopes for a win 2 May 2024 Jacobio’s KRAS contender raises more questions for Bristol 1 May 2024 Novartis re-ups on PeptiDream’s macrocyclic peptide promise 30 April 2024 Lilly’s Verzenio, and CDK4/6 inhibition, hits a dead end in prostate cancer 30 April 2024 Ono goes for growth with $2.4bn Deciphera buy 29 April 2024 Load More